Zdroje a cesty šíření vankomycin-rezistentních enterokoků u hemato-onkologických pacientů
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F06%3A00003150" target="_blank" >RIV/61989592:15110/06:00003150 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients
Popis výsledku v původním jazyce
Recently, the importance of gram-positive, often multiresistant, bacteria, bacteria in the etiopathogenesis of - particularly nosocomial - infectious has increased. Among these, a significant role is played by vancomycin-resistant enterococci (VRE) present especially in patients with hematooncological diseases and those in intensive care units. Although they mostly represent mere colonization of the gastrointestinal tract they can also cause serious infections which are difficult to mamage therapeutically. VRE were first isolated in Europe in 1986 and a year later in the USA. At present, VRE are described in other countries in the world. In the Czech Republic, VRE were first reported at the Department of Hemato-oncology, University Hospital Olomouc (DHO) in 1997. The presented study aims at analysing an increased prevalence of VRE in the DHO patients in early 2005, assessing their importance and formulating a hypothesis concerning their source and potential transmission pathways as bas
Název v anglickém jazyce
Sources and pathways of spread of vancomycin-resistant enterococci in hemato-onkological patients
Popis výsledku anglicky
Recently, the importance of gram-positive, often multiresistant, bacteria, bacteria in the etiopathogenesis of - particularly nosocomial - infectious has increased. Among these, a significant role is played by vancomycin-resistant enterococci (VRE) present especially in patients with hematooncological diseases and those in intensive care units. Although they mostly represent mere colonization of the gastrointestinal tract they can also cause serious infections which are difficult to mamage therapeutically. VRE were first isolated in Europe in 1986 and a year later in the USA. At present, VRE are described in other countries in the world. In the Czech Republic, VRE were first reported at the Department of Hemato-oncology, University Hospital Olomouc (DHO) in 1997. The presented study aims at analysing an increased prevalence of VRE in the DHO patients in early 2005, assessing their importance and formulating a hypothesis concerning their source and potential transmission pathways as bas
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
EE - Mikrobiologie, virologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NR9065" target="_blank" >NR9065: Real-time PCR detekce stafylokoků a enterokoků, průkaz faktorů rezistence a virulence</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2006
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Svazek periodika
150
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
4
Strana od-do
117-120
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—